The clinical significance of low level viremia during treatment with cART- Martin Markowitz, MD

Asian Conference on Hepatitis and AIDS (ACHA) 2017

PI based mono and dual-therapy- Bonaventura Clotet, MD, PhD

Asian Conference on Hepatitis and AIDS (ACHA) 2017

The clinical significance of low level viremia during treatment with cART- Martin Markowitz, MD

Asian Conference on Hepatitis and AIDS (ACHA) 2017

ARV toxicities and management- Fujie Zhang, MD, PhD

Asian Conference on Hepatitis and AIDS (ACHA) 2017

ARV toxicities and management- Fujie Zhang, MD, PhD

Asian Conference on Hepatitis and AIDS (ACHA) 2017

Adolescents and HIV: Guiding and Protecting the Vulnerable Population- Dushyantha Jayaweera, MD

Asian Conference on Hepatitis and AIDS (ACHA) 2017

Adolescents and HIV: Guiding and Protecting the Vulnerable Population- Dushyantha Jayaweera, MD

Asian Conference on Hepatitis and AIDS (ACHA) 2017

Local situation in Turkey | Serhat Unal, MD

Central and Eastern European Meeting on Viral Hepatitis and HIV 2016

Local situation in Russia | Vadim Rassokhin, MD

Central and Eastern European Meeting on Viral Hepatitis and HIV 2016

State-of-the-art treatment of Hepatitis B | Cihan Yurdaydin, MD

Central and Eastern European Meeting on Viral Hepatitis and HIV 2016

Prospects for Cure | Patrick Kennedy

Central and Eastern European Meeting on Viral Hepatitis and HIV 2016

(Abstract) The effect of lamivudine- versus tenofovir-containing antiretroviral regimen on hepatitis B infection in a cohort of HIV infected long term survivors | A. Temereanca

Central and Eastern European Meeting on Viral Hepatitis and HIV 2016

(Abstract) The prevalence of HBV, HCV and HIV infection in Romania - a nationwide screening program for surveillance of viral infections | O. Sandulescu

Central and Eastern European Meeting on Viral Hepatitis and HIV 2016

IVDU | Pavel Khaykin, MD

Central and Eastern European Meeting on Viral Hepatitis and HIV 2016

Update of new drugs | Cihan Yurdaydin, MD

Central and Eastern European Meeting on Viral Hepatitis and HIV 2016

Drug-Drug Interactions: considerations | Anca Streinu-Cercel, MD, PhD

Central and Eastern European Meeting on Viral Hepatitis and HIV 2016

Tackling the issues: Caring for HIV-positive women today | Anna Maria Geretti, MD, PhD, FRCPath

Central and Eastern European Meeting on Viral Hepatitis and HIV 2016

HIV and Pediatrics in Central Europe | Mariana Mărdărescu, MD, PhD

Central and Eastern European Meeting on Viral Hepatitis and HIV 2016

(Abstract) HCV reinfection in HCV/HIV coinfected patients treated for VHC in AIDS Center Prague | V. Aster

Central and Eastern European Meeting on Viral Hepatitis and HIV 2016

(Abstract) Expression of NS4 HCV in liver cells of HIV/HCV co-infected patients | N. Matsiyeuskaya

Central and Eastern European Meeting on Viral Hepatitis and HIV 2016

(Abstract) Chronic Hepatitis C Treatment among HIV/HCV co-infected PWID in Ukraine: communitysupported treatment model experience | T. Barnard

Central and Eastern European Meeting on Viral Hepatitis and HIV 2016

(Abstract) Quality of life in patients with HCV/ HIV co-infection | O. Shevchenko

Central and Eastern European Meeting on Viral Hepatitis and HIV 2016

(Abstract) Predictors of HIV co-infection in HCV infected patients in Serbia | M. Stanojevic

Central and Eastern European Meeting on Viral Hepatitis and HIV 2016

Local situation in Romania | Oana Săndulescu, MD, PhD

Central and Eastern European Meeting on Viral Hepatitis and HIV 2016